Evidence map›Paper›PMID 42642199›Full record

ArticleZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2026

[Protective effects and underlying mechanisms of bone marrow mesenchymal stem cells-derived apoptotic extracellular vesicles in acute kidney injury].

Zehuan Lin, Jiaman Chen, Tao Lin, Shuyun Liu, Jingping Liu

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zehuan LinDepartment of Urology Institute of Urology, NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
Jiaman ChenDepartment of Urology Institute of Urology, NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
Tao LinDepartment of Urology Institute of Urology, NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
Shuyun LiuDepartment of Urology Institute of Urology, NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
Jingping LiuDepartment of Urology Institute of Urology, NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To compare the characteristic differences between apoptotic extracellular vesicle (ApoEV) and non-apoptotic cell-derived extracellular vesicle (NCEV) from bone marrow mesenchymal stem cells (BMSCs), and to explore their therapeutic effects on inflammatory macrophages and cisplatin-induced acute kidney injury (AKI) in mice. Methods: Staurosporine (STS) was used to induce apoptosis in BMSCs, and the apoptotic model was verified by cell morphology observation, Annexin V/propidium iodide double-staining flow cytometry, and Western blot. NCEV and ApoEV were isolated via differential centrifugation combined with ultracentrifugation, and characterized using transmission electron microscopy, nanoparticle tracking analysis, and Western blot. The particle yield and protein yield of extracellular vesicles (EV) per unit donor cell were compared between the two groups. EVs were labeled with DiD, and the uptake of EV by RAW264.7 macrophages was detected using laser scanning confocal microscopy and flow cytometry. Lipopolysaccharide (LPS) was applied to stimulate RAW264.7 cells to establish an Results: After STS treatment, BMSCs exhibited typical apoptotic morphology with increased early and late apoptotic rates, alongside upregulated expression of Cleaved Caspase-3 and Bcl-2-associated X protein (Bax). Both NCEV and ApoEV presented spherical or quasi-spherical structures enclosed by a lipid bilayer membrane, with similar particle sizes and Zeta potentials. Bax and tumor susceptibility gene 101 protein were detected in both vesicles, while Cleaved Caspase-3 and Bax were detectable in ApoEV. The particle yield and protein yield of ApoEV were (5.626±0.302)-fold and (2.972±0.124)-fold higher than those of NCEV, respectively ( Conclusion: ApoEV possess higher production yield, enhanced macrophage uptake capacity and superior anti-inflammatory regulatory activity compared with NCEV. Both ApoEV and NCEV can alleviate renal injury in cisplatin-induced AKI, providing experimental evidence supporting the translational application of ApoEV for AKI treatment.

Indexed as

Acute Kidney InjuryApoptosisBone Marrow CellsExtracellular VesiclesMesenchymal Stem CellsAnimalsCisplatinDisease Models, AnimalLipopolysaccharidesMacrophagesMaleMiceMice, Inbred C57BLRAW 264.7 CellsReactive Oxygen SpeciesStaurosporineCisplatinLipopolysaccharidesReactive Oxygen SpeciesStaurosporineacute kidney injuryapoptotic extracellular vesiclesBone marrow mesenchymal stem cellsmacrophagesmice

Identifiers

PMID42642199
PMCPMC13489733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.